en
/
sv
About Elicera
Elicera in brief
Board
Management
Elicera's history
Immuno-oncology
What is immuno-oncology?
Oncolytic virus
CAR T-cell therapy
Technology
Strengths
ELC-001
ELC-100
ELC-201
ELC-301
ELC-401
Patents
Pipeline
Pipeline
Clinical trials
Investors
Press Releases
Articles of Association
General Meeting
Board
Management
the Share
Financial Reports
Financial Calendar
Events
News
News
Press Releases
Planned IPO
Events
Contact
Management
Jamal El-Mosleh
CEO and co-founder
Ingvar Karlsson
Chief Financial Officer
Magnus Essand
Chief Scientific Officer, Board member and co-founder
Di Yu
Head of Translational Research and Technical Operations and co-founder
